FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely gynaecology, venereology and immunology, and is applicable for local immunocorrection of female infectious-inflammatory urogenital diseases caused by sexually-transmitted microorganisms. For this purpose, with underlying drug-induced therapy, the immunomodulatory therapy is used from first day of therapy by magnetic laser exposure on a uterus neck. The uterus neck is exposed by a gynecologic speculum which is removed after the procedure is completed. The magnetic laser exposure immediately covers a cervical canal. That is ensured by using a low-intensity laser with variable pulse generation. The magnetic field intensity makes 1.25 T. Pulse train frequency per minute is 30. A pulse interval is 100 msec. Length of the exposure is 5 minutes. The therapeutic course is 10 procedures.
EFFECT: method provides higher complex clinical effectiveness ensured by normalising local immunity factors, namely functional activity recovery of neutrophilic granulocytes of the cervical canal, higher concentration of pro-inflammatory cytokines, immunoglobulins A, M, G in the cervical canal.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF PERSISTENCE OF ONCOGENIC HUMAN PAPILLOMA VIRUS IN CERVICAL EPITHELIUM | 2012 |
|
RU2520710C1 |
WAY OF LOCAL IMMUNOTHERAPY OF SEPTIC WOUNDS OF MAXILLOFACIAL AREA | 2007 |
|
RU2361626C2 |
METHOD FOR TREATMENT OF RECURRENT VULVOVAGINAL CANDIDIASIS | 2016 |
|
RU2642666C1 |
METHOD OF TREATING UROGENITAL CANDIDIASIS USING ULTRASONIC CAVITATION AND PHOTOCHROMOTHERAPY | 2019 |
|
RU2704470C1 |
METHOD OF TREATING VAGINAL DISBIOSES AND VAGINITES IN FEMALES SUFFERING CHRONIC SALPINGO-OOPHORITIS | 2010 |
|
RU2445135C1 |
METHOD FOR LOCAL IMMUNOCORRECTION OF PURULENT WOUNDS OF ORAL AREA | 2005 |
|
RU2311174C2 |
METHOD OF INCREASING CLINICAL IMMUNE EFFICIENCY OF GENITAL HERPES THERAPY USING INTRAVASCULAR BLOOD LASER EXPOSURE | 2015 |
|
RU2602304C1 |
METHOD FOR USING IMMUNOLOGICAL MARKERS FOR PREDICTION OF PROLIFERATIONS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH PAPILLOMAVIRUS INFECTION | 2012 |
|
RU2520746C1 |
METHOD OF PREDICTING UNFAVOURABLE COURSE OF LOCALLY SPREAD FORMS OF HUMAN PAPILLOMA VIRUS-ASSOCIATED CERVICAL CANCER | 2012 |
|
RU2504326C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF III DEGREE AND PRE-INVASIVE CERVICAL CANCER, ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2012 |
|
RU2506892C1 |
Authors
Dates
2012-07-10—Published
2009-05-14—Filed